{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T15:10:27Z","timestamp":1787065827642,"version":"build-2736575974"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Cardiovascular Diseases"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.acvd.2023.11.006","type":"journal-article","created":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T17:31:39Z","timestamp":1700760699000},"page":"84-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Recurrent venous thromboembolism in anticoagulated cancer patients: Diagnosis and treatment"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8214-3010","authenticated-orcid":false,"given":"Laurent","family":"Bertoletti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1559-8055","authenticated-orcid":false,"given":"Philippe","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1337-1826","authenticated-orcid":false,"given":"Antoine","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Espitia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannot","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Couturaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1760-7880","authenticated-orcid":false,"given":"Isabelle","family":"Mah\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acvd.2023.11.006_bib0355","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1182\/blood.2020007338","article-title":"Venous thromboembolism in cancer patients: a population-based cohort study","volume":"137","author":"Mulder","year":"2021","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2023.11.006_bib0360","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.thromres.2015.06.030","article-title":"Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study","volume":"136","author":"Heit","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.006_bib0365","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s11239-020-02180-x","article-title":"Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE","volume":"50","author":"Weitz","year":"2020","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2023.11.006_bib0370","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1111\/jth.15491","article-title":"Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: a systematic review and meta-analysis","volume":"19","author":"Khan","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0375","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1200\/JCO.2018.78.8034","article-title":"Comparison of an oral factor Xa inhibitor with low molecular weight heparin in patients with cancer with venous thromboembolism: results of a randomized trial (SELECT-D)","volume":"36","author":"Young","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0380","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1056\/NEJMoa025313","article-title":"Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer","volume":"349","author":"Lee","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0385","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0042-1758835","article-title":"Survival implications of thrombus recurrence or bleeding in cancer patients receiving anticoagulation for venous thromboembolism treatment","volume":"123","author":"McBane Ii","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0390","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1055\/s-0040-1708481","article-title":"A meta-analysis of case fatality rates of recurrent venous thromboembolism and major bleeding in patients with cancer","volume":"120","author":"Abdulla","year":"2020","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0395","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/jama.2015.9243","article-title":"Tinzaparin vs warfarin for treatment of acute venous thromboembolism in patients with active cancer: a randomized clinical trial","volume":"314","author":"Lee","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2023.11.006_bib0400","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2023.7843","article-title":"Direct oral anticoagulants vs low-molecular-weight heparin and recurrent VTE in patients with cancer: a randomized clinical trial","volume":"329","author":"Schrag","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.acvd.2023.11.006_bib0405","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1111\/jth.14769","article-title":"Definition of pulmonary embolism-related death and classification of the cause of death in venous thromboembolism studies: communication from the SSC of the ISTH","volume":"18","author":"Tritschler","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0410","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.thromres.2015.07.011","article-title":"Treatment of venous thromboembolism in patients with cancer: a network meta-analysis comparing efficacy and safety of anticoagulants","volume":"136","author":"Posch","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.006_bib0415","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chest.2021.09.037","article-title":"Rivaroxaban versus dalteparin in cancer-associated thromboembolism: a randomized trial","volume":"161","author":"Planquette","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2023.11.006_bib0420","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1056\/NEJMoa1711948","article-title":"Edoxaban for the treatment of cancer-associated venous thromboembolism","volume":"378","author":"Raskob","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0425","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0430","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.3324\/haematol.2019.222828","article-title":"Accuracy of the Ottawa score in risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism: a systematic review and meta-analysis","volume":"105","author":"Delluc","year":"2020","journal-title":"Haematologica"},{"key":"10.1016\/j.acvd.2023.11.006_bib0435","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/a-1486-7497","article-title":"Failure of the Ottawa score to predict the risk of recurrent venous thromboembolism in cancer patients: the prospective PREDICARE cohort study","volume":"122","author":"Girard","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0440","first-page":"228","article-title":"Prediction of on treatment recurrent venous thromboembolism in patients with cancer: an individual patient data meta-analysis of randomized controlled trials","volume":"7","author":"Lanting","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0445","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1111\/jth.12301","article-title":"The diagnosis of symptomatic recurrent pulmonary embolism and deep vein thrombosis: guidance from the SSC of the ISTH","volume":"11","author":"Ageno","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0450","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1160\/TH05-12-0791","article-title":"Clinical usefulness of D-dimer testing in cancer patients with suspected pulmonary embolism","volume":"95","author":"Righini","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0455","first-page":"225","article-title":"Diagnostic strategies in patients on anticoagulation presenting with a suspicion of recurrent venous thromboembolism","volume":"7","author":"Mai","year":"2023","journal-title":"J Thrombos Haemostas"},{"key":"10.1016\/j.acvd.2023.11.006_bib0460","first-page":"1026","article-title":"The diagnostic performance of the YEARS and PEGeD algorithm in patients with prior venous thrombosis suspected of pulmonary embolism","volume":"7","author":"Martens","year":"2023","journal-title":"J Thrombos Haemostas"},{"key":"10.1016\/j.acvd.2023.11.006_bib0465","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01647-2019","volume":"54","author":"Konstantinides","year":"2019","journal-title":"Eur Respir J"},{"key":"10.1016\/j.acvd.2023.11.006_bib0470","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1055\/a-2057-8672","article-title":"Modern lung scintigraphy techniques for optimising the diagnosis of pulmonary embolism: Great expectations, still waiting to be met","volume":"123","author":"Konstantinides","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0475","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1055\/a-1986-8878","article-title":"Diagnostic accuracy of V\/Q and Q SPECT\/CT in patients with suspected acute pulmonary embolism: a systematic review and meta-analysis","volume":"123","author":"Squizzato","year":"2023","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0480","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.chest.2022.01.013","article-title":"Beyond clots in the pulmonary circulation: pulmonary artery tumors mimicking pulmonary embolism","volume":"161","author":"Lashari","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2023.11.006_bib0485","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1186\/s12957-017-1223-3","article-title":"Pulmonary tumor embolism secondary to soft tissue and bone sarcomas: a case report and literature review","volume":"15","author":"Latchana","year":"2017","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0490","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1111\/jth.12625","article-title":"The risk of venous thromboembolism in renal cell carcinoma patients with residual tumor thrombus: reply","volume":"12","author":"Pena","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0495","doi-asserted-by":"crossref","first-page":"180065","DOI":"10.1183\/16000617.0065-2018","article-title":"Tumoral pulmonary hypertension","volume":"28","author":"Price","year":"2019","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.acvd.2023.11.006_bib0500","first-page":"10","article-title":"Pulmonary hypertension due to pulmonary artery obstructions by malignant tumoral cells","volume":"76","author":"Murgier","year":"2019","journal-title":"Respir Med Res"},{"key":"10.1016\/j.acvd.2023.11.006_bib0505","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1111\/jth.14900","article-title":"Diagnosing deep vein thrombosis in cancer patients with suspected symptoms: an individual participant data meta-analysis","volume":"18","author":"Takada","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0510","doi-asserted-by":"crossref","first-page":"195","DOI":"10.5482\/HAMO-13-06-0029","article-title":"Diagnosis of recurrent deep vein thrombosis","volume":"33","author":"Schellong","year":"2013","journal-title":"Hamostaseologie"},{"key":"10.1016\/j.acvd.2023.11.006_bib0515","doi-asserted-by":"crossref","first-page":"955","DOI":"10.7326\/0003-4819-137-12-200212170-00008","article-title":"Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism","volume":"137","author":"Prandoni","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0520","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-150-9-200905050-00003","article-title":"Residual thrombosis on ultrasonography to guide the duration of anticoagulation in patients with deep venous thrombosis: a randomized trial","volume":"150","author":"Prandoni","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0525","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11239-015-1311-6","article-title":"The epidemiology of venous thromboembolism","volume":"41","author":"Heit","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2023.11.006_bib0530","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2141.2011.08578.x","article-title":"Residual venous thrombosis as predictive factor for recurrent venous thromboembolim in patients with proximal deep vein thrombosis: a sytematic review","volume":"153","author":"Tan","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0535","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1148\/radiology.170.3.2644660","article-title":"Recurrent deep venous thrombosis: limitations of US","volume":"170","author":"Cronan","year":"1989","journal-title":"Radiology"},{"key":"10.1016\/j.acvd.2023.11.006_bib0540","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM198106253042602","article-title":"Cost effectiveness of clinical diagnosis, venography, and noninvasive testing in patients with symptomatic deep-vein thrombosis","volume":"304","author":"Hull","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0545","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1182\/blood.2019004114","article-title":"Magnetic resonance imaging for diagnosis of recurrent ipsilateral deep vein thrombosis","volume":"135","author":"van Dam","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2023.11.006_bib0550","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s11239-021-02538-9","article-title":"Non-contrast-enhanced magnetic resonance imaging technique diagnoses DVT and classifies thrombus","volume":"53","author":"Shen","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.acvd.2023.11.006_bib0555","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s12968-019-0552-5","article-title":"Diffusion weighted cardiovascular magnetic resonance imaging for discriminating acute from non-acute deep venous Thrombus","volume":"21","author":"Wu","year":"2019","journal-title":"J Cardiovasc Magn Reson"},{"key":"10.1016\/j.acvd.2023.11.006_bib0560","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1177\/0268355520939375","article-title":"Non-contrast-enhanced magnetic resonance imaging: Objective figures in differentiation between acute and chronic deep venous thrombosis in the lower extremities","volume":"35","author":"Kao","year":"2020","journal-title":"Phlebology"},{"key":"10.1016\/j.acvd.2023.11.006_bib0565","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1111\/jth.13403","article-title":"Current and future perspectives in imaging of venous thromboembolism","volume":"14","author":"Dronkers","year":"2016","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0570","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.urolonc.2022.11.021","article-title":"Renal cell carcinoma with tumor thrombus: a review of relevant anatomy and surgical techniques for the general urologist","volume":"41","author":"Almatari","year":"2023","journal-title":"Urol Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0575","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12957-020-01914-8","article-title":"Resection of recurrent hepatocellular carcinoma with thrombi in the inferior vena cava, right atrium, and phrenic vein: a report of three cases","volume":"18","author":"Tomita","year":"2020","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0580","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1111\/echo.15586","article-title":"A rare case of retro-hepatic inferior vena caval leiomyosarcoma\u00a0\u2013\u00a0computed tomography, surgical and intraoperative echocardiography imaging","volume":"40","author":"Raj","year":"2023","journal-title":"Echocardiography"},{"key":"10.1016\/j.acvd.2023.11.006_bib0585","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/j.1538-7836.2009.03326.x","article-title":"Dose escalation of low molecular weight heparin to manage recurrent venous thromboembolic events despite systemic anticoagulation in cancer patients","volume":"7","author":"Carrier","year":"2009","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0590","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.thromres.2014.04.028","article-title":"Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis","volume":"134","author":"Ihaddadene","year":"2014","journal-title":"Thromb Res"},{"key":"10.1016\/j.acvd.2023.11.006_bib0595","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/jth.12955","article-title":"Recurrent venous thromboembolism in anticoagulated patients with cancer: management and short-term prognosis","volume":"13","author":"Schulman","year":"2015","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0600","first-page":"101056","article-title":"French guidelines for the treatment of cancer-associated venous thromboembolism\u00a0\u2013\u00a02023 update","volume":"84","author":"Mah\u00e9","year":"2023","journal-title":"Respir Med Res"},{"key":"10.1016\/j.acvd.2023.11.006_bib0605","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.23.00294","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO guideline update","volume":"41","author":"Key","year":"2023","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0610","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS)","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.acvd.2023.11.006_bib0615","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1016\/S1470-2045(22)00160-7","article-title":"2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19","volume":"23","author":"Farge","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0620","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jaccao.2021.03.001","article-title":"Venous and arterial thromboembolism in patients with cancer: JACC: CardioOncology State-of-the-Art Review","volume":"3","author":"Gervaso","year":"2021","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0625","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ejim.2022.02.020","article-title":"Consensus on prevention and treatment of cancer-associated thrombosis (CAT) in controversial clinical situations with low levels of evidence","volume":"100","author":"Jimenez-Fonseca","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0630","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/bjh.18276","article-title":"Unanswered questions in cancer-associated thrombosis","volume":"198","author":"Sanfilippo","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0635","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1111\/jth.12338","article-title":"Management of challenging cases of patients with cancer-associated thrombosis including recurrent thrombosis and bleeding: guidance from the SSC of the ISTH","volume":"11","author":"Carrier","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0640","doi-asserted-by":"crossref","first-page":"e12773","DOI":"10.1002\/rth2.12773","article-title":"Recurrent thrombosis rescued by fondaparinux in high-risk patients: a case series","volume":"6","author":"Tanguay","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0645","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1200\/JCO.19.01461","article-title":"Venous thromboembolism prophylaxis and treatment in patients with cancer: ASCO Clinical practice guideline update","volume":"38","author":"Key","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0650","doi-asserted-by":"crossref","first-page":"e180452","DOI":"10.1001\/jamanetworkopen.2018.0452","article-title":"Association of inferior vena cava filter placement for venous thromboembolic disease and a contraindication to anticoagulation with 30-day mortality","volume":"1","author":"Turner","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.acvd.2023.11.006_bib0655","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2022.12.014","article-title":"Venous thromboembolism in cancer patients: ESMO Clinical Practice Guideline","volume":"34","author":"Falanga","year":"2023","journal-title":"Ann Oncol"},{"key":"10.1016\/j.acvd.2023.11.006_bib0660","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jth.13564","article-title":"Inferior vena cava filters","volume":"15","author":"Duffett","year":"2017","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0665","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1182\/blood-2017-03-742304","article-title":"treat recurrent venous thromboembolism in patients receiving anticoagulant therapy","volume":"129","author":"Schulman","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.acvd.2023.11.006_bib0670","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.chest.2021.09.037","article-title":"Rivaroxaban vs dalteparin in cancer-associated thromboembolism: a randomized trial","volume":"161","author":"Planquette","year":"2022","journal-title":"Chest"},{"key":"10.1016\/j.acvd.2023.11.006_bib0675","first-page":"2865","article-title":"Investigating the benefit of adding a vena cava filter to anticoagulation with fondaparinux sodium in patients with cancer and venous thromboembolism in a prospective randomized clinical trial","volume":"20","author":"Barginear","year":"2012","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.acvd.2023.11.006_bib0680","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/bloodadvances.2020003442","article-title":"American Society of Hematology 2021 guidelines for management of venous thromboembolism: prevention and treatment in patients with cancer","volume":"5","author":"Lyman","year":"2021","journal-title":"Blood Adv"},{"key":"10.1016\/j.acvd.2023.11.006_bib0685","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jcin.2016.08.039","article-title":"Outcomes associated with inferior vena cava filters among patients with thromboembolic recurrence during anticoagulant therapy","volume":"9","author":"Mellado","year":"2016","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.acvd.2023.11.006_bib0690","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.amjmed.2014.06.025","article-title":"Inferior vena cava filter usage, complications, and retrieval rate in cancer patients","volume":"127","author":"Abtahian","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/j.acvd.2023.11.006_bib0695","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.jtha.2023.04.010","article-title":"Predictors of recurrence of cancer-associated venous thromboembolism after discontinuation of anticoagulant therapy: a multicenter cohort study","volume":"21","author":"Lap\u00e9bie","year":"2023","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.acvd.2023.11.006_bib0700","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00330-022-09266-5","article-title":"Temporary inferior vena cava filters factors associated with non-removal","volume":"33","author":"Dehbi","year":"2023","journal-title":"Eur Radiol"}],"container-title":["Archives of Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213623005156?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1875213623005156?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:49:07Z","timestamp":1761745747000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1875213623005156"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S1875213623005156"],"URL":"https:\/\/doi.org\/10.1016\/j.acvd.2023.11.006","relation":{},"ISSN":["1875-2136"],"issn-type":[{"value":"1875-2136","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recurrent venous thromboembolism in anticoagulated cancer patients: Diagnosis and treatment","name":"articletitle","label":"Article Title"},{"value":"Archives of Cardiovascular Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acvd.2023.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}